# Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency

> **NCT01327703** · PHASE4 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 87 (actual)

## Conditions studied

- Exocrine Pancreatic Insufficiency
- Cystic Fibrosis

## Interventions

- **DRUG:** Panzytrat® 25,000
- **DRUG:** Kreon® 25,000

## Key facts

- **NCT ID:** NCT01327703
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2014-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01327703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01327703, "Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01327703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*